Archive
Here you can find the archive of all Press Releases prior to 2018
Filter by date:
Showing 677 press releases before 2019
-
AstraZeneca appoints Dr Sean Bohen as Executive Vice President of Global Medicines Development and Chief Medical Officer
-
AstraZeneca and Peregrine Pharmaceuticals to collaborate on immuno-oncology combination clinical trial
-
MedImmune enters into strategic cancer vaccine collaboration and license agreement with Inovio Pharmaceuticals
-
AstraZeneca and Heptares Therapeutics enter agreement to develop novel immuno-oncology treatments
-
MedImmune and Mirati Therapeutics partner on immuno-oncology combination in lung cancer
-
AstraZeneca and Isis Pharmaceuticals to discover and develop antisense drugs for cardiovascular, metabolic and renal diseases
-
AstraZeneca PLC H1 2015 results
-
AstraZeneca further sharpens focus through agreement with Genzyme for rare disease medicine Caprelsa
-
AstraZeneca provides update on selumetinib in uveal melanoma
-
AstraZeneca completes agreement with Tillotts Pharma for Entocort
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 (0)1223 344 800
Kim Blomley
Director Global Media Relations (Oncology)
+44 (0)1223 344 800
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Fiona Cookson
Director Global Media Relations (Covid-19)
+44 (0)1223 344 800
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
